Yahoo Web Search

Search results

  1. 2 days ago · Analyst Daniel Grosslight of Citi reiterated a Buy rating on Cencora (COR – Research Report), retaining the price target of $280.00. Daniel Grosslight has given his Buy rating due to a ...

  2. 6 days ago · Cencora, formerly AmerisourceBergen, is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain. Latest quarterly results. Q2 2024. News Release. Presentation. Webcast. Form 10-Q. See all quarters.

  3. May 1, 2024 · News. View All News. Cencora Reports Fiscal 2024 Second Quarter Results. May 1, 2024. Download. Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase Year-Over-Year. Second Quarter GAAP Diluted EPS of $2.09 and Adjusted Diluted EPS of $3.80. Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50 for Fiscal 2024.

  4. May 2, 2024 · COR. Revenue: $68.4 billion, up 8%. Adjusted EPS: Growth of 9%. Consolidated Gross Profit: $2.5 billion, up 7%. Consolidated Operating Income: $1.0 billion, an increase of 11%. Net Interest...

  5. May 15, 2024 · August 31, 2023. Type News. Pharmaceuticals manufacturer and distributor AmerisourceBergen Corp. has changed its name to Cencora. Under the new name Cencora, the company unifies its 46,000 employees – across several global business segments – under one identity, company officials said in an Aug. 30 news release.

  6. May 1, 2024 · Business Wire. Wed, May 1, 2024, 6:30 AM 19 min read. In this article: COR. Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase Year-Over-Year. Second Quarter GAAP Diluted EPS...

  7. May 1, 2024 · COR. BSX. Cencora, Inc. COR reported second-quarter fiscal 2024 adjusted earnings per share (EPS) of $3.80, which beat the Zacks Consensus Estimate of 3.65 by 4.1%. The bottom line also improved...

  1. People also search for